16 September 2026 editorial review · Item
MiniMed Flex pump: review notes
These notes document the scope actually reviewed, including source-access limits. They are not independent clinical certification or a guarantee that every claim was verified.
Read the item evidence page →Thriving evidence review — 16 September 2026
Record: MiniMed Flex pump
Scope and findings:
- Read September company launch/pipeline announcement; corrected timing/European access and separated submission, CE marking, enrollment and approval. No new efficacy inferred.
- Live GATEWAY registry status ACTIVE_NOT_RECRUITING, actual 389, estimated primary/completion January 2027; updated enrollment language independently of company Vivera milestone.
Primary sources checked:
Limits: The review is restricted to the scopes above. Historical efficacy estimates, editorial scoring and country-specific access were not fully reverified unless expressly stated. A manufacturer or conference report retains that evidence level.